Cranbrook Wealth Management’s Eli Lilly LLY Stock Holding History

Cranbrook Wealth Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$344K	Hold	287	–	–	0.06%	107
2026 Q1	$264K	Hold	287	–	–	0.05%	112
2025 Q4	$308K	Sell	287 -67	-19%	-$64.1K	0.06%	104
2025 Q3	$270K	Buy	354 +107	+43%	+$79.6K	0.05%	108
2025 Q2	$193K	Buy	247 +17	+7%	+$13.2K	0.04%	120
2025 Q1	$190K	Buy	230 +2	+0.9%	+$1.66K	0.04%	114
2024 Q4	$176K	Buy	228 +8	+4%	+$6.62K	0.04%	115
2024 Q3	$195K	Buy	220 +1	+0.5%	+$899	0.04%	112
2024 Q2	$198K	Hold	219	–	–	0.05%	106
2024 Q1	$170K	Sell	219 -20	-8%	-$14.2K	0.04%	98
2023 Q4	$139K	Buy	239 +90	+60%	+$52.5K	0.04%	106
2023 Q3	$80K	Hold	149	–	–	0.02%	130
2023 Q2	$69.9K	Hold	149	–	–	0.02%	138
2023 Q1	$51.2K	Hold	149	–	–	0.01%	153
2022 Q4	$54.5K	Hold	149	–	–	0.01%	149
2022 Q3	$48K	Hold	149	–	–	0.01%	169
2022 Q2	$48K	Sell	149 -20	-12%	-$6K	0.01%	171
2022 Q1	$49K	Sell	169 -30	-15%	-$7.72K	0.01%	189
2021 Q4	$55K	Hold	199	–	–	0.01%	177
2021 Q3	$46K	Buy	199 +30	+18%	+$7.4K	0.01%	196
2021 Q2	$39K	Sell	169 -12	-7%	-$2.41K	0.01%	204
2021 Q1	$34K	Buy	181 +112	+162%	+$21.9K	0.01%	210
2020 Q4	$12K	Hold	69	–	–	﹤0.01%	227
2020 Q3	$10K	Hold	69	–	–	﹤0.01%	212
2020 Q2	$11K	Hold	69	–	–	﹤0.01%	206
2020 Q1	$10K	Sell	69 -70	-50%	-$9.62K	﹤0.01%	199
2019 Q4	$18K	Hold	139	–	–	0.01%	182
2019 Q3	$16K	Hold	139	–	–	﹤0.01%	180
2019 Q2	$15K	Hold	139	–	–	﹤0.01%	182
2019 Q1	$18K	Hold	139	–	–	0.01%	174
2018 Q4	$16K	Hold	139	–	–	0.01%	172
2018 Q3	$15K	Hold	139	–	–	0.01%	169
2018 Q2	$12K	Hold	139	–	–	﹤0.01%	171
2018 Q1	$11K	Hold	139	–	–	﹤0.01%	177
2017 Q4	$12K	Hold	139	–	–	﹤0.01%	175
2017 Q3	$12K	Hold	139	–	–	0.01%	172
2017 Q2	$11K	Hold	139	–	–	﹤0.01%	184
2017 Q1	$12K	Hold	139	–	–	0.01%	168
2016 Q4	$10K	Hold	139	–	–	﹤0.01%	177
2016 Q3	$11K	Hold	139	–	–	0.01%	164
2016 Q2	$11K	Hold	139	–	–	0.01%	149
2016 Q1	$10K	Hold	139	–	–	0.01%	160
2015 Q4	$12K	Hold	139	–	–	0.01%	152
2015 Q3	$12K	Hold	139	–	–	0.01%	156
2015 Q2	$12K	Hold	139	–	–	0.01%	162
2015 Q1	$10K	Buy	+139	New	+$9.9K	0.01%	164
2014 Q1	–	Sell	-55	Closed	–	–	190
2013 Q4	$0	Buy	+55	New	+$2.75K	﹤0.01%	230

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cranbrook Wealth Management's LLY Position: Q2 2026 in Review

Cranbrook Wealth Management held its Eli Lilly (LLY) position steady in Q2 2026 at 287 shares worth $344K. The position accounts for 0.06% of the portfolio, ranked #107.

Cranbrook Wealth Management first reported a position in LLY in Q4 2013 and has held it in 47 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Cranbrook Wealth Management held 287 shares of Eli Lilly worth $344K as of Q2 2026.
Cranbrook Wealth Management left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 0.06% of Cranbrook Wealth Management's portfolio in Q2 2026, its #107 holding.
Cranbrook Wealth Management first reported a position in Eli Lilly in Q4 2013 and has held it in 47 quarters since.
4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cranbrook Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.